MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
155 hedge funds and large institutions have $718M invested in Momenta Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
Holders
155
Holding in Top 10
1
Calls
$1.93M
Puts
$524K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$6.96M | |
| 3 | +$6.93M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.76M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.92M |
Top Sellers
| 1 | -$5.79M | |
| 2 | -$2.56M | |
| 3 | -$1.78M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.61M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.57M |